Skip to main content

What is Gocovri (amantadine) and how does it work?

Medically reviewed by Melisa Puckey, BPharm. Last updated on June 5, 2025.

Official Answer by Drugs.com

Gocovri (amantadine) is used to treat involuntary movements (dyskinesia) in patients with Parkinson’s disease who are being treated with levodopa-based medicines and who may also be on dopaminergic medications.

Gocovri is also used as an add-on treatment to levodopa/carbidopa for Parkinson’s disease patients who are experiencing “off” episodes.

The way Gocovri works to treat dyskinesia in Parkinson's disease is currently unknown.

Gocovri is an extended release capsule that helps improve rigidity, tremors and the involuntary movements and therefore increases the quality of life of Parkinson’s patients.

What is dyskinesia?

Dyskinesia is when you have uncontrollable, erratic, writhing movements of the face, arms, legs and and/or trunk. There can also be head bobbing, fidgeting or rocking and swaying movements. These unpredictable movements can be extremely frustrating and interfere with how well a person functions in their everyday life.

What is Parkinsons’ Disease?

Parkinson’s disease is a brain and nervous system disease that gradually gets worse over time.

There is a gradual loss of nerve cells in a part of the brain called the substantia nigra, these cells usually make dopamine which controls and coordinates body movements. As there are less cells that make dopamine, the dopamine levels become low and this results in body movements becoming slow and awkward. Other symptoms can be tremor (usually at rest), dyskinesia, rigid limbs and gait and balance problems.

Treatment of Parkinson’s disease symptoms is often started with levodopa, which helps replace the lost dopamine. Levodopa works well to reduce movement disorders and dyskinesia, although long term use can result in levodopa-induced dyskinesia.

Gocovri is used in Parkinson’s disease patients who are on levodopa-based medication and/or dopaminergic medications but are still struggling with dyskinesia. The addition of Gocovri can reduce dyskinesia and uncontrolled movements and therefore reduce disability and increase quality of life.

Related questions

How does Gocovri work?

The way Gocovri reduces dyskinesia Is not known.

Gocovri is known to inhibit NMDA receptors and may have direct and indirect effects on dopamine neurons.

Bottom line:

References

Read next

How much does Ingrezza cost and will insurance cover it?

Ingrezza costs approximately $7,921 for 28 capsules of the 40mg strength and $8,702 for 28 capsules of the 80mg strength, or an annual cost of $102,973 to $113,126 per year; however, most people do not pay this amount. People with commercial insurance may qualify for a $0 copay for each Ingrezza prescription through the INBRACE Support Program and approximately 46% of Medicare Part D and Medicare Advantage plans cover Ingrezza. For people with Medicaid, most states require prior authorization for Ingrezza and the satisfaction of certain criteria before it can be funded. Continue reading

Which pharmacies can dispense Ingrezza?

A specialty pharmacy will dispense your Ingrezza or Ingrezza Sprinkle and will mail it directly to you via overnight mail. Your doctor will send your prescription to the appropriate pharmacy, and they will contact you to verify the information. Continue reading

Austedo (deutetrabenazine) vs Xenazine (tetrabenazine): How do they compare?

The main differences between deutetrabenazine (Austedo, Austedo XR) and tetrabenazine (Xenazine) are in their chemical structure and pharmacokinetics. The addition of deuterium to the Austedo compound lengthens the duration of action and may reduce certain side effects compared to Xenazine. Overall, the drugs are fairly similar with regards to drug class, warnings, side effects and potential drug interactions, but differ in their FDA-approved uses. Continue reading

See also:

Related medical questions

Drug information

Related support groups